

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of epidermis development (GO:0045683) | 8.02454447 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 7.36941043 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 7.36941043 |
| 4 | neutrophil mediated immunity (GO:0002446) | 7.09728691 |
| 5 | polyketide metabolic process (GO:0030638) | 7.08659943 |
| 6 | doxorubicin metabolic process (GO:0044598) | 7.08659943 |
| 7 | daunorubicin metabolic process (GO:0044597) | 7.08659943 |
| 8 | intestinal absorption (GO:0050892) | 6.89569545 |
| 9 | sterol catabolic process (GO:0016127) | 6.84997430 |
| 10 | cholesterol catabolic process (GO:0006707) | 6.84997430 |
| 11 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 6.52324151 |
| 12 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 6.39612369 |
| 13 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.32898119 |
| 14 | arachidonic acid secretion (GO:0050482) | 6.32718455 |
| 15 | icosanoid secretion (GO:0032309) | 6.32718455 |
| 16 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 6.28131517 |
| 17 | * cobalamin metabolic process (GO:0009235) | 6.19980846 |
| 18 | transcytosis (GO:0045056) | 6.18401927 |
| 19 | peptidyl-proline hydroxylation (GO:0019511) | 6.12227055 |
| 20 | endocrine pancreas development (GO:0031018) | 5.95800784 |
| 21 | intestinal epithelial cell development (GO:0060576) | 5.88986820 |
| 22 | regulation of keratinocyte differentiation (GO:0045616) | 5.82761115 |
| 23 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.78392151 |
| 24 | positive regulation of nuclease activity (GO:0032075) | 5.56484597 |
| 25 | regulation of keratinocyte proliferation (GO:0010837) | 5.45500125 |
| 26 | * tetrapyrrole metabolic process (GO:0033013) | 5.33212639 |
| 27 | fatty acid derivative transport (GO:1901571) | 5.28581688 |
| 28 | icosanoid transport (GO:0071715) | 5.28581688 |
| 29 | myeloid leukocyte mediated immunity (GO:0002444) | 5.05882507 |
| 30 | cysteine metabolic process (GO:0006534) | 5.04842323 |
| 31 | regulation of nuclease activity (GO:0032069) | 5.04414341 |
| 32 | endoplasmic reticulum unfolded protein response (GO:0030968) | 5.01640182 |
| 33 | protein hydroxylation (GO:0018126) | 5.00659011 |
| 34 | proline biosynthetic process (GO:0006561) | 4.98985024 |
| 35 | innate immune response in mucosa (GO:0002227) | 4.86295203 |
| 36 | regulation of acrosome reaction (GO:0060046) | 4.85020041 |
| 37 | cellular response to unfolded protein (GO:0034620) | 4.83466787 |
| 38 | cellular protein catabolic process (GO:0044257) | 4.79261059 |
| 39 | acute-phase response (GO:0006953) | 4.74094127 |
| 40 | negative regulation of digestive system process (GO:0060457) | 4.74066238 |
| 41 | response to endoplasmic reticulum stress (GO:0034976) | 4.71841803 |
| 42 | membrane lipid catabolic process (GO:0046466) | 4.65933831 |
| 43 | ER-nucleus signaling pathway (GO:0006984) | 4.64996105 |
| 44 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 4.62680284 |
| 45 | polarized epithelial cell differentiation (GO:0030859) | 4.57669275 |
| 46 | ceramide catabolic process (GO:0046514) | 4.57127746 |
| 47 | cellular response to topologically incorrect protein (GO:0035967) | 4.56629542 |
| 48 | protein maturation by protein folding (GO:0022417) | 4.40343111 |
| 49 | phosphatidylserine metabolic process (GO:0006658) | 4.32692230 |
| 50 | regulation of phospholipase A2 activity (GO:0032429) | 4.31470043 |
| 51 | digestive system process (GO:0022600) | 4.23434519 |
| 52 | leukotriene metabolic process (GO:0006691) | 4.20759057 |
| 53 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.20558474 |
| 54 | glycolipid catabolic process (GO:0019377) | 4.20371978 |
| 55 | COPII vesicle coating (GO:0048208) | 4.17415537 |
| 56 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.14308461 |
| 57 | * water-soluble vitamin metabolic process (GO:0006767) | 4.09962769 |
| 58 | phospholipid catabolic process (GO:0009395) | 3.98510560 |
| 59 | mucosal immune response (GO:0002385) | 3.97680782 |
| 60 | pancreas development (GO:0031016) | 3.97643150 |
| 61 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.95523102 |
| 62 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.93912875 |
| 63 | response to unfolded protein (GO:0006986) | 3.90212720 |
| 64 | sterol transport (GO:0015918) | 3.86301231 |
| 65 | mitochondrial calcium ion transport (GO:0006851) | 3.86078739 |
| 66 | serine family amino acid biosynthetic process (GO:0009070) | 3.82303642 |
| 67 | 4-hydroxyproline metabolic process (GO:0019471) | 3.81156756 |
| 68 | maintenance of protein localization in organelle (GO:0072595) | 3.76267516 |
| 69 | antibacterial humoral response (GO:0019731) | 3.75466743 |
| 70 | homocysteine metabolic process (GO:0050667) | 3.74965707 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.74526544 |
| 72 | response to topologically incorrect protein (GO:0035966) | 3.73981145 |
| 73 | zinc ion transport (GO:0006829) | 3.70153525 |
| 74 | valine metabolic process (GO:0006573) | 3.70040615 |
| 75 | establishment of apical/basal cell polarity (GO:0035089) | 3.69642272 |
| 76 | phosphatidic acid biosynthetic process (GO:0006654) | 3.66143885 |
| 77 | phosphatidic acid metabolic process (GO:0046473) | 3.66143885 |
| 78 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.63090776 |
| 79 | glutathione derivative metabolic process (GO:1901685) | 3.62984515 |
| 80 | glutathione derivative biosynthetic process (GO:1901687) | 3.62984515 |
| 81 | organ or tissue specific immune response (GO:0002251) | 3.58456051 |
| 82 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.57040982 |
| 83 | alditol phosphate metabolic process (GO:0052646) | 3.56208523 |
| 84 | branched-chain amino acid catabolic process (GO:0009083) | 3.55033567 |
| 85 | regulation of epidermal cell differentiation (GO:0045604) | 3.54001604 |
| 86 | aspartate family amino acid catabolic process (GO:0009068) | 3.53947925 |
| 87 | peptidyl-asparagine modification (GO:0018196) | 3.49997325 |
| 88 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.49979700 |
| 89 | ER overload response (GO:0006983) | 3.49861596 |
| 90 | progesterone metabolic process (GO:0042448) | 3.47396709 |
| 91 | defense response to Gram-positive bacterium (GO:0050830) | 3.47145782 |
| 92 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.46032035 |
| 93 | antimicrobial humoral response (GO:0019730) | 3.45953732 |
| 94 | L-serine metabolic process (GO:0006563) | 3.44677253 |
| 95 | regulation of metalloenzyme activity (GO:0048552) | 3.43390814 |
| 96 | regulation of triglyceride catabolic process (GO:0010896) | 3.40673053 |
| 97 | positive regulation of wound healing (GO:0090303) | 3.35507772 |
| 98 | glutamine metabolic process (GO:0006541) | 3.34124923 |
| 99 | glycoside metabolic process (GO:0016137) | 3.33530823 |
| 100 | steroid catabolic process (GO:0006706) | 3.31968064 |
| 101 | negative regulation of epithelial cell differentiation (GO:0030857) | 3.31902251 |
| 102 | regulation of hormone metabolic process (GO:0032350) | 3.30571078 |
| 103 | acute inflammatory response (GO:0002526) | 3.30092715 |
| 104 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.26715818 |
| 105 | primary alcohol catabolic process (GO:0034310) | 3.25063884 |
| 106 | retinoid metabolic process (GO:0001523) | 3.24397158 |
| 107 | peptide catabolic process (GO:0043171) | 3.23747505 |
| 108 | signal peptide processing (GO:0006465) | 3.23091815 |
| 109 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.22267103 |
| 110 | * vitamin metabolic process (GO:0006766) | 3.21725214 |
| 111 | branched-chain amino acid metabolic process (GO:0009081) | 3.20752653 |
| 112 | icosanoid biosynthetic process (GO:0046456) | 3.18692636 |
| 113 | fatty acid derivative biosynthetic process (GO:1901570) | 3.18692636 |
| 114 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.18087626 |
| 115 | protein N-linked glycosylation (GO:0006487) | 3.17731946 |
| 116 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.14255438 |
| 117 | establishment of monopolar cell polarity (GO:0061162) | 3.14255438 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.13345944 |
| 119 | vesicle coating (GO:0006901) | 3.12765454 |
| 120 | proline metabolic process (GO:0006560) | 3.11841113 |
| 121 | Golgi organization (GO:0007030) | 3.11743068 |
| 122 | retinoic acid receptor signaling pathway (GO:0048384) | 3.06488792 |
| 123 | diterpenoid metabolic process (GO:0016101) | 3.05259244 |
| 124 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.04484718 |
| 125 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.03787058 |
| 126 | regulation of calcium ion import (GO:0090279) | 3.02485779 |
| 127 | negative regulation of hormone metabolic process (GO:0032351) | 2.99066473 |
| 128 | phototransduction, visible light (GO:0007603) | 2.95855655 |
| 129 | endothelial cell migration (GO:0043542) | 2.95760485 |
| 130 | macroautophagy (GO:0016236) | 2.94922768 |
| 131 | glandular epithelial cell differentiation (GO:0002067) | 2.93403574 |
| 132 | multicellular organismal metabolic process (GO:0044236) | 2.88287189 |
| 133 | peroxisome fission (GO:0016559) | 2.85219164 |
| 134 | phosphatidylglycerol metabolic process (GO:0046471) | 2.85036709 |
| 135 | atrioventricular valve morphogenesis (GO:0003181) | 2.82295209 |
| 136 | lung secretory cell differentiation (GO:0061140) | 2.81775199 |
| 137 | mitochondrion distribution (GO:0048311) | 2.79852980 |
| 138 | * extracellular matrix disassembly (GO:0022617) | 2.79183317 |
| 139 | positive regulation of heat generation (GO:0031652) | 2.79090158 |
| 140 | negative regulation of mRNA metabolic process (GO:1903312) | 2.78970029 |
| 141 | serine family amino acid metabolic process (GO:0009069) | 2.77732197 |
| 142 | creatine metabolic process (GO:0006600) | 2.77592481 |
| 143 | negative regulation of Notch signaling pathway (GO:0045746) | 2.75616318 |
| 144 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.72263750 |
| 145 | leukotriene biosynthetic process (GO:0019370) | 2.72258435 |
| 146 | cell redox homeostasis (GO:0045454) | 2.71794326 |
| 147 | sphingolipid catabolic process (GO:0030149) | 2.70861747 |
| 148 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.70624580 |
| 149 | retinal metabolic process (GO:0042574) | 2.70529230 |
| 150 | epithelial structure maintenance (GO:0010669) | 2.70514230 |
| 151 | cellular response to cadmium ion (GO:0071276) | 2.69707958 |
| 152 | membrane repolarization during action potential (GO:0086011) | 2.68317737 |
| 153 | terpenoid metabolic process (GO:0006721) | 2.67059156 |
| 154 | regulation of response to osmotic stress (GO:0047484) | 2.66629650 |
| 155 | L-phenylalanine catabolic process (GO:0006559) | 2.65616731 |
| 156 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.65616731 |
| 157 | negative regulation of cell fate commitment (GO:0010454) | 2.63292151 |
| 158 | type B pancreatic cell development (GO:0003323) | 2.58469947 |
| 159 | regulation of fever generation (GO:0031620) | 2.57540469 |
| 160 | nephron tubule morphogenesis (GO:0072078) | 2.56701279 |
| 161 | nephron epithelium morphogenesis (GO:0072088) | 2.56701279 |
| 162 | embryonic foregut morphogenesis (GO:0048617) | 2.56339559 |
| 163 | multicellular organismal catabolic process (GO:0044243) | 2.54734735 |
| 164 | L-phenylalanine metabolic process (GO:0006558) | 2.54310383 |
| 165 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.54310383 |
| 166 | regulation of oxidative stress-induced cell death (GO:1903201) | 2.53305743 |
| 167 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.51061571 |
| 168 | protein targeting to ER (GO:0045047) | 2.50820483 |
| 169 | cholesterol transport (GO:0030301) | 2.50748262 |
| 170 | exocrine pancreas development (GO:0031017) | 18.0339608 |
| 171 | intestinal cholesterol absorption (GO:0030299) | 15.2015644 |
| 172 | * digestion (GO:0007586) | 11.7578131 |
| 173 | protein retention in ER lumen (GO:0006621) | 11.1044053 |
| 174 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 10.7285393 |
| 175 | negative regulation of epidermal cell differentiation (GO:0045605) | 10.5829854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.72314382 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.66311154 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.96012305 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.34168895 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.69319939 |
| 6 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.68516890 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.68228839 |
| 8 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.68189764 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63132023 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.40262644 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.35911934 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29465734 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.20330611 |
| 14 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.16834300 |
| 15 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11059080 |
| 16 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.10881448 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.10059771 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.07328850 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.01731388 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96969248 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96019648 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93223702 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.85379683 |
| 24 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.78732240 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77423120 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74832660 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73449373 |
| 28 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.66708332 |
| 29 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.65227515 |
| 30 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.64545056 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63178498 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.61699567 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60907259 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.59751594 |
| 35 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.56421210 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52468647 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48145562 |
| 38 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.47561350 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.41129304 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40629770 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.39305919 |
| 42 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38015654 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37262921 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37001171 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36883654 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36690505 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35469105 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34717792 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33907577 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33309369 |
| 51 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.33132515 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32702167 |
| 53 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31918391 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31549702 |
| 55 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30491983 |
| 56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30262535 |
| 57 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29758086 |
| 58 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.29423296 |
| 59 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.27967752 |
| 60 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.26917497 |
| 61 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.26615178 |
| 62 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.26517043 |
| 63 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.26161398 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25161063 |
| 65 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.25107858 |
| 66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24679655 |
| 67 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24231073 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24206339 |
| 69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23891347 |
| 70 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.22488659 |
| 71 | NFYA_21822215_ChIP-Seq_K562_Human | 1.20241876 |
| 72 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.19741465 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18282911 |
| 74 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.18251024 |
| 75 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16903076 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16586226 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15445017 |
| 78 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.15224402 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15132158 |
| 80 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14389801 |
| 81 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14204041 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13517937 |
| 83 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.13300955 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12693579 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11420775 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11420775 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11148600 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10636006 |
| 89 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.10578073 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10559609 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10081773 |
| 92 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09821045 |
| 93 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.08712807 |
| 94 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.07777044 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07600867 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06908283 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06621346 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06211013 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05857339 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04327229 |
| 101 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.04189525 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03638238 |
| 103 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03380040 |
| 104 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.03315131 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02381490 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01083953 |
| 107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00479824 |
| 108 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00311176 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99389622 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99281969 |
| 111 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99031289 |
| 112 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98049855 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97945813 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96641718 |
| 115 | ERA_21632823_ChIP-Seq_H3396_Human | 0.95760175 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95155197 |
| 117 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.94794667 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94783177 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94631307 |
| 120 | NFYB_21822215_ChIP-Seq_K562_Human | 0.94590845 |
| 121 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93030296 |
| 122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92955015 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92801977 |
| 124 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.91200084 |
| 125 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.90828994 |
| 126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89192414 |
| 127 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88290367 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88206122 |
| 129 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88107449 |
| 130 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87794315 |
| 131 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.87655077 |
| 132 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.87655077 |
| 133 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.87655077 |
| 134 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.87639046 |
| 135 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87496110 |
| 136 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.87436461 |
| 137 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87155668 |
| 138 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86773053 |
| 139 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82121975 |
| 140 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81122651 |
| 141 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.80961478 |
| 142 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80939558 |
| 143 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79937813 |
| 144 | P300_27268052_Chip-Seq_Bcells_Human | 0.79090411 |
| 145 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.79015332 |
| 146 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.76570125 |
| 147 | AR_20517297_ChIP-Seq_VCAP_Human | 0.75693438 |
| 148 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75335372 |
| 149 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75335372 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74946936 |
| 151 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74432482 |
| 152 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73555754 |
| 153 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.73443691 |
| 154 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.73443691 |
| 155 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.72250243 |
| 156 | P300_19829295_ChIP-Seq_ESCs_Human | 0.72045733 |
| 157 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.70998613 |
| 158 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.69528069 |
| 159 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.69086232 |
| 160 | TBL1_22424771_ChIP-Seq_293T_Human | 0.66541344 |
| 161 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64704134 |
| 162 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64704134 |
| 163 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.62146588 |
| 164 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.60828489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 8.81190099 |
| 2 | MP0001666_abnormal_nutrient_absorption | 7.66013931 |
| 3 | MP0005220_abnormal_exocrine_pancreas | 6.31968297 |
| 4 | MP0003868_abnormal_feces_composition | 5.17791806 |
| 5 | MP0005084_abnormal_gallbladder_morpholo | 4.95561505 |
| 6 | MP0005365_abnormal_bile_salt | 4.94565327 |
| 7 | MP0003283_abnormal_digestive_organ | 3.15721137 |
| 8 | MP0003122_maternal_imprinting | 2.92449124 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.81818098 |
| 10 | MP0010386_abnormal_urinary_bladder | 2.69008268 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.68362380 |
| 12 | MP0002693_abnormal_pancreas_physiology | 2.65850052 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.65309797 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.65165606 |
| 15 | MP0001944_abnormal_pancreas_morphology | 2.41929321 |
| 16 | MP0003959_abnormal_lean_body | 2.37160169 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.33614536 |
| 18 | MP0001664_abnormal_digestion | 2.20187808 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.16213744 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.97966504 |
| 21 | MP0003123_paternal_imprinting | 1.96389013 |
| 22 | MP0002928_abnormal_bile_duct | 1.94625929 |
| 23 | MP0006054_spinal_hemorrhage | 1.86972660 |
| 24 | MP0003011_delayed_dark_adaptation | 1.79254820 |
| 25 | MP0003252_abnormal_bile_duct | 1.78027314 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.77048441 |
| 27 | MP0004233_abnormal_muscle_weight | 1.53213565 |
| 28 | MP0003195_calcinosis | 1.39038062 |
| 29 | MP0005448_abnormal_energy_balance | 1.21340013 |
| 30 | MP0004272_abnormal_basement_membrane | 1.16629671 |
| 31 | MP0003638_abnormal_response/metabolism_ | 1.15178396 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.09394311 |
| 33 | MP0002132_abnormal_respiratory_system | 1.06979779 |
| 34 | MP0001756_abnormal_urination | 1.04079655 |
| 35 | MP0008961_abnormal_basal_metabolism | 1.02982979 |
| 36 | MP0000470_abnormal_stomach_morphology | 1.02025328 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.01414157 |
| 38 | MP0002078_abnormal_glucose_homeostasis | 0.97450283 |
| 39 | MP0003300_gastrointestinal_ulcer | 0.97124292 |
| 40 | MP0003045_fibrosis | 0.96712878 |
| 41 | MP0003119_abnormal_digestive_system | 0.95813251 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 0.91718378 |
| 43 | MP0009840_abnormal_foam_cell | 0.90021259 |
| 44 | MP0009672_abnormal_birth_weight | 0.84903638 |
| 45 | MP0009703_decreased_birth_body | 0.84207315 |
| 46 | MP0009384_cardiac_valve_regurgitation | 0.83188547 |
| 47 | MP0008004_abnormal_stomach_pH | 0.81359876 |
| 48 | MP0000613_abnormal_salivary_gland | 0.80915312 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 0.78548803 |
| 50 | MP0002163_abnormal_gland_morphology | 0.77863431 |
| 51 | MP0002909_abnormal_adrenal_gland | 0.74585794 |
| 52 | MP0005332_abnormal_amino_acid | 0.73016972 |
| 53 | MP0000538_abnormal_urinary_bladder | 0.72841912 |
| 54 | MP0003121_genomic_imprinting | 0.72611216 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 0.72575292 |
| 56 | MP0010329_abnormal_lipoprotein_level | 0.72084227 |
| 57 | MP0005165_increased_susceptibility_to | 0.71853666 |
| 58 | MP0005408_hypopigmentation | 0.70677925 |
| 59 | MP0000537_abnormal_urethra_morphology | 0.70160575 |
| 60 | MP0003115_abnormal_respiratory_system | 0.70147042 |
| 61 | MP0009643_abnormal_urine_homeostasis | 0.70018281 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 0.69065115 |
| 63 | MP0000490_abnormal_crypts_of | 0.66653249 |
| 64 | MP0005451_abnormal_body_composition | 0.65601902 |
| 65 | MP0002896_abnormal_bone_mineralization | 0.65232964 |
| 66 | MP0003953_abnormal_hormone_level | 0.64101875 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 0.62285810 |
| 68 | MP0000462_abnormal_digestive_system | 0.60645760 |
| 69 | MP0003879_abnormal_hair_cell | 0.59241963 |
| 70 | MP0008872_abnormal_physiological_respon | 0.59166874 |
| 71 | MP0005076_abnormal_cell_differentiation | 0.58527990 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.58353738 |
| 73 | MP0003943_abnormal_hepatobiliary_system | 0.58240581 |
| 74 | MP0003942_abnormal_urinary_system | 0.57121774 |
| 75 | MP0003186_abnormal_redox_activity | 0.56271555 |
| 76 | MP0003941_abnormal_skin_development | 0.55867857 |
| 77 | MP0002938_white_spotting | 0.54797369 |
| 78 | MP0005375_adipose_tissue_phenotype | 0.52876077 |
| 79 | MP0001502_abnormal_circadian_rhythm | 0.51909591 |
| 80 | MP0001270_distended_abdomen | 0.51069734 |
| 81 | MP0004858_abnormal_nervous_system | 0.50705586 |
| 82 | MP0000598_abnormal_liver_morphology | 0.50353922 |
| 83 | MP0000013_abnormal_adipose_tissue | 0.50111388 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.50008166 |
| 85 | MP0005187_abnormal_penis_morphology | 0.49843495 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.49086577 |
| 87 | MP0001731_abnormal_postnatal_growth | 0.48740047 |
| 88 | MP0005452_abnormal_adipose_tissue | 0.48251462 |
| 89 | MP0002970_abnormal_white_adipose | 0.47608542 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.47107147 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.46631070 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 0.46479244 |
| 93 | MP0002060_abnormal_skin_morphology | 0.46123977 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.46087886 |
| 95 | MP0001542_abnormal_bone_strength | 0.45613976 |
| 96 | MP0000367_abnormal_coat/_hair | 0.45597675 |
| 97 | MP0010678_abnormal_skin_adnexa | 0.45336401 |
| 98 | MP0004197_abnormal_fetal_growth/weight/ | 0.44744744 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.44201653 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.42889671 |
| 101 | MP0001348_abnormal_lacrimal_gland | 0.41754728 |
| 102 | MP0008995_early_reproductive_senescence | 0.41730697 |
| 103 | MP0002796_impaired_skin_barrier | 0.41405142 |
| 104 | MP0001873_stomach_inflammation | 0.41316878 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 0.41289544 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.41038159 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.40391381 |
| 108 | MP0005535_abnormal_body_temperature | 0.39864290 |
| 109 | MP0005379_endocrine/exocrine_gland_phen | 0.38679631 |
| 110 | MP0003436_decreased_susceptibility_to | 0.38427986 |
| 111 | MP0008469_abnormal_protein_level | 0.37110324 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.36190525 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.35489918 |
| 114 | MP0003567_abnormal_fetal_cardiomyocyte | 0.34974273 |
| 115 | MP0000609_abnormal_liver_physiology | 0.34945840 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.34757131 |
| 117 | MP0000377_abnormal_hair_follicle | 0.34671269 |
| 118 | MP0001340_abnormal_eyelid_morphology | 0.34488790 |
| 119 | MP0001849_ear_inflammation | 0.34361884 |
| 120 | MP0000566_synostosis | 0.33838816 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.33686601 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.33411604 |
| 123 | MP0002089_abnormal_postnatal_growth/wei | 0.33206950 |
| 124 | MP0000428_abnormal_craniofacial_morphol | 0.32430756 |
| 125 | MP0003828_pulmonary_edema | 0.31954597 |
| 126 | MP0005334_abnormal_fat_pad | 0.30188628 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.30132395 |
| 128 | MP0001661_extended_life_span | 0.29653558 |
| 129 | MP0003646_muscle_fatigue | 0.29138125 |
| 130 | MP0010352_gastrointestinal_tract_polyps | 0.28705997 |
| 131 | MP0004043_abnormal_pH_regulation | 0.28500285 |
| 132 | MP0003866_abnormal_defecation | 0.28372354 |
| 133 | MP0000955_abnormal_spinal_cord | 0.27889697 |
| 134 | MP0002127_abnormal_cardiovascular_syste | 0.27822695 |
| 135 | MP0000750_abnormal_muscle_regeneration | 0.27552403 |
| 136 | MP0005058_abnormal_lysosome_morphology | 0.27439627 |
| 137 | MP0004134_abnormal_chest_morphology | 0.27007491 |
| 138 | MP0002295_abnormal_pulmonary_circulatio | 0.26563258 |
| 139 | MP0003795_abnormal_bone_structure | 0.26418447 |
| 140 | MP0004133_heterotaxia | 0.26304126 |
| 141 | MP0005275_abnormal_skin_tensile | 0.26216358 |
| 142 | MP0005646_abnormal_pituitary_gland | 0.26121586 |
| 143 | MP0000467_abnormal_esophagus_morphology | 0.25963725 |
| 144 | MP0002069_abnormal_eating/drinking_beha | 0.25749069 |
| 145 | MP0001963_abnormal_hearing_physiology | 0.24955174 |
| 146 | MP0002168_other_aberrant_phenotype | 0.23611733 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.22853998 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.22590049 |
| 149 | MP0005410_abnormal_fertilization | 0.21651351 |
| 150 | MP0005166_decreased_susceptibility_to | 0.18943058 |
| 151 | MP0005670_abnormal_white_adipose | 0.18017734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 7.09025602 |
| 2 | Exocrine pancreatic insufficiency (HP:0001738) | 6.10850238 |
| 3 | Fat malabsorption (HP:0002630) | 5.91491965 |
| 4 | Abnormal pancreas size (HP:0012094) | 5.40848617 |
| 5 | Gout (HP:0001997) | 5.40730436 |
| 6 | Decreased subcutaneous fat (HP:0001002) | 5.28053501 |
| 7 | Hypoproteinemia (HP:0003075) | 5.17982161 |
| 8 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.07809766 |
| 9 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.07809766 |
| 10 | Short chin (HP:0000331) | 4.92168058 |
| 11 | Abnormality of subcutaneous fat tissue (HP:0001001) | 4.78326144 |
| 12 | Type I diabetes mellitus (HP:0100651) | 4.60264786 |
| 13 | Maternal diabetes (HP:0009800) | 4.23574296 |
| 14 | Late onset (HP:0003584) | 4.00024750 |
| 15 | Ketoacidosis (HP:0001993) | 3.95797483 |
| 16 | Goiter (HP:0000853) | 3.68036239 |
| 17 | Abnormality of proline metabolism (HP:0010907) | 3.61993825 |
| 18 | Hydroxyprolinuria (HP:0003080) | 3.61993825 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.41431373 |
| 20 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.38286031 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.25675802 |
| 22 | Joint stiffness (HP:0001387) | 3.22049092 |
| 23 | Pancreatitis (HP:0001733) | 3.17978236 |
| 24 | Hypoglycemic seizures (HP:0002173) | 3.16683289 |
| 25 | Ketosis (HP:0001946) | 3.14382867 |
| 26 | Tetraparesis (HP:0002273) | 3.09643241 |
| 27 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.09305388 |
| 28 | Tubulointerstitial fibrosis (HP:0005576) | 3.04509995 |
| 29 | Anal atresia (HP:0002023) | 2.97657870 |
| 30 | Hypotension (HP:0002615) | 2.88717622 |
| 31 | Hypoplasia of the pons (HP:0012110) | 2.85328208 |
| 32 | Large for gestational age (HP:0001520) | 2.75953951 |
| 33 | Sex reversal (HP:0012245) | 2.70942469 |
| 34 | Abnormal sex determination (HP:0012244) | 2.70942469 |
| 35 | Hyperglycemia (HP:0003074) | 2.67764028 |
| 36 | Rectal prolapse (HP:0002035) | 2.67289190 |
| 37 | Asymmetry of the thorax (HP:0001555) | 2.66361400 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.65558356 |
| 39 | Esophageal varix (HP:0002040) | 2.63795670 |
| 40 | Enlarged penis (HP:0000040) | 2.62641279 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.62054107 |
| 42 | Absent eyelashes (HP:0000561) | 2.57652911 |
| 43 | Vascular calcification (HP:0004934) | 2.57242110 |
| 44 | Lymphangioma (HP:0100764) | 2.57056513 |
| 45 | Abnormality of the pons (HP:0007361) | 2.56179853 |
| 46 | Congenital glaucoma (HP:0001087) | 2.54094441 |
| 47 | Unilateral renal agenesis (HP:0000122) | 2.51458283 |
| 48 | Abnormality of the nasal septum (HP:0000419) | 2.49332152 |
| 49 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.46357058 |
| 50 | Ankyloglossia (HP:0010296) | 2.45273275 |
| 51 | Congenital, generalized hypertrichosis (HP:0004540) | 2.42734668 |
| 52 | Premature skin wrinkling (HP:0100678) | 2.40906022 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34081777 |
| 54 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.33249847 |
| 55 | Insulin resistance (HP:0000855) | 2.33083630 |
| 56 | Hepatoblastoma (HP:0002884) | 2.29326788 |
| 57 | Right ventricular cardiomyopathy (HP:0011663) | 2.27457692 |
| 58 | Germ cell neoplasia (HP:0100728) | 2.23954487 |
| 59 | Prenatal maternal abnormality (HP:0002686) | 2.22859403 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.21701881 |
| 61 | Ventricular fibrillation (HP:0001663) | 2.20571890 |
| 62 | Pectus carinatum (HP:0000768) | 2.19607820 |
| 63 | Fragile skin (HP:0001030) | 2.18707651 |
| 64 | Stenosis of the external auditory canal (HP:0000402) | 2.18648645 |
| 65 | Hyperuricemia (HP:0002149) | 2.17133287 |
| 66 | Increased purine levels (HP:0004368) | 2.17133287 |
| 67 | Thin bony cortex (HP:0002753) | 2.16123854 |
| 68 | Symptomatic seizures (HP:0011145) | 2.12481167 |
| 69 | Facial shape deformation (HP:0011334) | 2.10804078 |
| 70 | Potter facies (HP:0002009) | 2.10804078 |
| 71 | Fatigue (HP:0012378) | 2.08682273 |
| 72 | Atrophic scars (HP:0001075) | 2.08460951 |
| 73 | Cortical dysplasia (HP:0002539) | 2.07041690 |
| 74 | Abnormality of dentin (HP:0010299) | 2.03577177 |
| 75 | Hyperphosphatemia (HP:0002905) | 2.03434029 |
| 76 | Diaphragmatic weakness (HP:0009113) | 2.02466191 |
| 77 | Male infertility (HP:0003251) | 2.00348789 |
| 78 | Enlarged kidneys (HP:0000105) | 1.99457171 |
| 79 | Thoracolumbar scoliosis (HP:0002944) | 1.96355073 |
| 80 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.95932381 |
| 81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95727323 |
| 82 | Barrel-shaped chest (HP:0001552) | 1.95329999 |
| 83 | Tubular atrophy (HP:0000092) | 1.93323311 |
| 84 | Testicular neoplasm (HP:0010788) | 1.92744476 |
| 85 | Optic nerve hypoplasia (HP:0000609) | 1.92678141 |
| 86 | Type II lissencephaly (HP:0007260) | 1.91684431 |
| 87 | Tubulointerstitial abnormality (HP:0001969) | 1.89782793 |
| 88 | Mitral valve prolapse (HP:0001634) | 1.88293752 |
| 89 | Abnormality of the renal cortex (HP:0011035) | 1.86824760 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 1.86057968 |
| 91 | Renal duplication (HP:0000075) | 1.84287161 |
| 92 | Abnormal hemoglobin (HP:0011902) | 1.84172533 |
| 93 | Ileus (HP:0002595) | 1.83659881 |
| 94 | Patent foramen ovale (HP:0001655) | 1.83016229 |
| 95 | Rough bone trabeculation (HP:0100670) | 1.82935156 |
| 96 | Macroorchidism (HP:0000053) | 1.81229566 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.80491771 |
| 98 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79218558 |
| 99 | Abnormality of alanine metabolism (HP:0010916) | 1.79218558 |
| 100 | Hyperalaninemia (HP:0003348) | 1.79218558 |
| 101 | Paraparesis (HP:0002385) | 1.78940658 |
| 102 | Severe short stature (HP:0003510) | 1.78324507 |
| 103 | Carpal bone hypoplasia (HP:0001498) | 1.78027091 |
| 104 | Cerebral aneurysm (HP:0004944) | 1.77009684 |
| 105 | Ankle contracture (HP:0006466) | 1.76575534 |
| 106 | Tubulointerstitial nephritis (HP:0001970) | 1.76543369 |
| 107 | Neonatal death (HP:0003811) | 1.75742588 |
| 108 | Buphthalmos (HP:0000557) | 1.75053649 |
| 109 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.73115332 |
| 110 | Congenital malformation of the right heart (HP:0011723) | 1.72043799 |
| 111 | Double outlet right ventricle (HP:0001719) | 1.72043799 |
| 112 | Abnormality of oral frenula (HP:0000190) | 1.70944899 |
| 113 | Infantile muscular hypotonia (HP:0008947) | 1.70487190 |
| 114 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.68953903 |
| 115 | Reduced antithrombin III activity (HP:0001976) | 1.67785428 |
| 116 | Progressive muscle weakness (HP:0003323) | 1.66833010 |
| 117 | Shallow orbits (HP:0000586) | 1.66695845 |
| 118 | Blue sclerae (HP:0000592) | 1.65139208 |
| 119 | Hyperextensible skin (HP:0000974) | 1.65097631 |
| 120 | Hypsarrhythmia (HP:0002521) | 1.63616004 |
| 121 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.63371485 |
| 122 | Micronodular cirrhosis (HP:0001413) | 1.63198466 |
| 123 | Turricephaly (HP:0000262) | 1.63186824 |
| 124 | Abdominal pain (HP:0002027) | 1.63133583 |
| 125 | Disproportionate tall stature (HP:0001519) | 1.61737754 |
| 126 | Disproportionate short-trunk short stature (HP:0003521) | 1.60899426 |
| 127 | Protrusio acetabuli (HP:0003179) | 1.60665846 |
| 128 | Distal lower limb muscle weakness (HP:0009053) | 1.60346648 |
| 129 | Periodontitis (HP:0000704) | 1.59951681 |
| 130 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.59694720 |
| 131 | Abnormal biliary tract morphology (HP:0012440) | 1.59399294 |
| 132 | Biconcave vertebral bodies (HP:0004586) | 1.58899426 |
| 133 | Hypoplasia of the odontoid process (HP:0003311) | 1.57923819 |
| 134 | Abnormal tarsal ossification (HP:0008369) | 1.57151035 |
| 135 | Bladder diverticulum (HP:0000015) | 1.57000776 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.56105403 |
| 137 | Abnormality of methionine metabolism (HP:0010901) | 1.55997965 |
| 138 | Abdominal distention (HP:0003270) | 1.55775252 |
| 139 | Glycosuria (HP:0003076) | 1.53814878 |
| 140 | Abnormality of urine glucose concentration (HP:0011016) | 1.53814878 |
| 141 | Type I transferrin isoform profile (HP:0003642) | 1.53201829 |
| 142 | Down-sloping shoulders (HP:0200021) | 1.51687454 |
| 143 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.49079248 |
| 144 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.49079248 |
| 145 | Abnormal protein glycosylation (HP:0012346) | 1.49079248 |
| 146 | Abnormal glycosylation (HP:0012345) | 1.49079248 |
| 147 | Glossoptosis (HP:0000162) | 1.48604146 |
| 148 | Increased CSF protein (HP:0002922) | 1.46657169 |
| 149 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.45365526 |
| 150 | Popliteal pterygium (HP:0009756) | 1.44171237 |
| 151 | Glomerulonephritis (HP:0000099) | 1.43277511 |
| 152 | Gowers sign (HP:0003391) | 1.41951227 |
| 153 | Periauricular skin pits (HP:0100277) | 1.41890670 |
| 154 | Preauricular pit (HP:0004467) | 1.41890670 |
| 155 | Spinal muscular atrophy (HP:0007269) | 1.41860973 |
| 156 | Glucose intolerance (HP:0000833) | 1.41384972 |
| 157 | Sparse eyelashes (HP:0000653) | 1.39382743 |
| 158 | Abnormal trabecular bone morphology (HP:0100671) | 1.37764044 |
| 159 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.37035116 |
| 160 | Fetal akinesia sequence (HP:0001989) | 1.35973589 |
| 161 | Epiphyseal dysplasia (HP:0002656) | 1.34589152 |
| 162 | Renal salt wasting (HP:0000127) | 1.33836511 |
| 163 | Increased serum pyruvate (HP:0003542) | 1.32139739 |
| 164 | Stridor (HP:0010307) | 1.30526298 |
| 165 | Limb-girdle muscle atrophy (HP:0003797) | 1.25222674 |
| 166 | Hand muscle atrophy (HP:0009130) | 1.25193970 |
| 167 | Bifid uvula (HP:0000193) | 1.25174128 |
| 168 | Rhabdomyolysis (HP:0003201) | 1.23653754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.34930453 |
| 2 | PDK2 | 5.33190993 |
| 3 | TRIB3 | 5.32829503 |
| 4 | PKN2 | 4.99042451 |
| 5 | ERN1 | 4.96193384 |
| 6 | MAP2K2 | 3.14374164 |
| 7 | STK24 | 2.89005714 |
| 8 | EIF2AK3 | 2.85920186 |
| 9 | INSRR | 2.75484363 |
| 10 | MAP3K12 | 2.43421982 |
| 11 | PTK6 | 2.29598670 |
| 12 | GRK1 | 2.16070844 |
| 13 | TAOK3 | 2.12938565 |
| 14 | PASK | 2.09326671 |
| 15 | RIPK1 | 1.96337500 |
| 16 | LATS1 | 1.95909072 |
| 17 | EEF2K | 1.93986544 |
| 18 | MAPK15 | 1.93731137 |
| 19 | OXSR1 | 1.76198733 |
| 20 | TBK1 | 1.74176368 |
| 21 | MAP3K6 | 1.74090877 |
| 22 | FLT3 | 1.73318530 |
| 23 | MAP3K10 | 1.73314932 |
| 24 | PDGFRA | 1.72275402 |
| 25 | SCYL2 | 1.72057456 |
| 26 | RPS6KB2 | 1.65406863 |
| 27 | PAK2 | 1.62780452 |
| 28 | ZAP70 | 1.47342278 |
| 29 | EIF2AK1 | 1.40170510 |
| 30 | PRKG2 | 1.39019918 |
| 31 | PRKD3 | 1.37406301 |
| 32 | FRK | 1.35181189 |
| 33 | WNK4 | 1.34216468 |
| 34 | BMPR1B | 1.31286175 |
| 35 | NEK6 | 1.29849258 |
| 36 | PDGFRB | 1.28761466 |
| 37 | LRRK2 | 1.25036810 |
| 38 | MST4 | 1.23542567 |
| 39 | FGFR4 | 1.21533114 |
| 40 | MAP3K2 | 1.21497921 |
| 41 | STK16 | 1.20547908 |
| 42 | MAP2K1 | 1.20158459 |
| 43 | SIK1 | 1.17234806 |
| 44 | IRAK1 | 1.15565162 |
| 45 | PTK2 | 1.15121452 |
| 46 | NLK | 1.14761417 |
| 47 | VRK2 | 1.12721878 |
| 48 | CAMKK1 | 1.10586678 |
| 49 | MTOR | 1.08487023 |
| 50 | FER | 1.05644171 |
| 51 | ERBB4 | 1.04727968 |
| 52 | MAPK7 | 1.03313705 |
| 53 | RET | 1.01004477 |
| 54 | MET | 0.98147256 |
| 55 | HIPK2 | 0.97243342 |
| 56 | IRAK2 | 0.95679803 |
| 57 | NTRK1 | 0.95321039 |
| 58 | MAPKAPK3 | 0.94060886 |
| 59 | PAK4 | 0.93197202 |
| 60 | DAPK1 | 0.92608623 |
| 61 | MAP3K1 | 0.91878368 |
| 62 | DYRK1B | 0.91632169 |
| 63 | EPHA3 | 0.90651510 |
| 64 | EPHB1 | 0.87769492 |
| 65 | PIM2 | 0.87548203 |
| 66 | DDR2 | 0.87508836 |
| 67 | MYLK | 0.83837263 |
| 68 | STK38L | 0.83760565 |
| 69 | ILK | 0.80624351 |
| 70 | NME1 | 0.80568518 |
| 71 | TRPM7 | 0.77477908 |
| 72 | NME2 | 0.77358449 |
| 73 | PRKCH | 0.76158241 |
| 74 | SGK3 | 0.72217007 |
| 75 | STK3 | 0.71470562 |
| 76 | PRKCI | 0.67480196 |
| 77 | TESK1 | 0.66807665 |
| 78 | CDK19 | 0.64416583 |
| 79 | CDK8 | 0.64189741 |
| 80 | TNIK | 0.61956748 |
| 81 | DAPK2 | 0.61148908 |
| 82 | IRAK3 | 0.56493212 |
| 83 | PRKCE | 0.55606085 |
| 84 | KSR2 | 0.51583612 |
| 85 | DYRK1A | 0.48998417 |
| 86 | MAP3K14 | 0.48108787 |
| 87 | TAOK1 | 0.46869599 |
| 88 | ERBB2 | 0.46207499 |
| 89 | SGK2 | 0.45456181 |
| 90 | IKBKE | 0.45135670 |
| 91 | SRPK1 | 0.44185226 |
| 92 | MUSK | 0.43934864 |
| 93 | PRKD1 | 0.43463759 |
| 94 | PRKD2 | 0.42740424 |
| 95 | ROCK1 | 0.40922513 |
| 96 | ICK | 0.39821814 |
| 97 | FGFR1 | 0.38881372 |
| 98 | LMTK2 | 0.38381237 |
| 99 | PRKCD | 0.38202377 |
| 100 | PRKCZ | 0.38064851 |
| 101 | MELK | 0.37706321 |
| 102 | IKBKB | 0.37667199 |
| 103 | CDK4 | 0.36318119 |
| 104 | EPHA2 | 0.35526899 |
| 105 | CSNK1E | 0.35467661 |
| 106 | MAPK12 | 0.34993879 |
| 107 | STK38 | 0.34678708 |
| 108 | CLK1 | 0.34050229 |
| 109 | WNK1 | 0.33588160 |
| 110 | MAPK1 | 0.32852544 |
| 111 | MAP3K7 | 0.32632946 |
| 112 | UHMK1 | 0.31744652 |
| 113 | CHUK | 0.31690627 |
| 114 | MAP3K8 | 0.31468616 |
| 115 | GSK3A | 0.30807566 |
| 116 | MAPK3 | 0.30566258 |
| 117 | PDPK1 | 0.29775260 |
| 118 | ALK | 0.29179611 |
| 119 | DAPK3 | 0.29157093 |
| 120 | VRK1 | 0.28893189 |
| 121 | PIK3CG | 0.28806659 |
| 122 | PRKAA1 | 0.28575299 |
| 123 | RPS6KA1 | 0.28497276 |
| 124 | PRKCQ | 0.28244209 |
| 125 | TYRO3 | 0.27443054 |
| 126 | JAK2 | 0.27351524 |
| 127 | MAP3K5 | 0.26803722 |
| 128 | SGK223 | 0.25353548 |
| 129 | SGK494 | 0.25353548 |
| 130 | TAOK2 | 0.25239630 |
| 131 | PRKACB | 0.25223854 |
| 132 | PAK3 | 0.24548941 |
| 133 | ADRBK2 | 0.23100799 |
| 134 | ERBB3 | 0.22525566 |
| 135 | TGFBR2 | 0.22209909 |
| 136 | PRKACA | 0.21619855 |
| 137 | SGK1 | 0.21213502 |
| 138 | AKT1 | 0.21130656 |
| 139 | TSSK6 | 0.20898289 |
| 140 | IGF1R | 0.20525195 |
| 141 | PRKCA | 0.20263259 |
| 142 | MAP3K3 | 0.20250073 |
| 143 | PRKAA2 | 0.19944614 |
| 144 | MAPK9 | 0.19689262 |
| 145 | PIK3CA | 0.19433152 |
| 146 | MST1R | 0.19074897 |
| 147 | CAMKK2 | 0.19026195 |
| 148 | AKT2 | 0.18087542 |
| 149 | STK39 | 0.17010647 |
| 150 | RPS6KB1 | 0.16060982 |
| 151 | FGFR2 | 0.15942246 |
| 152 | PDK1 | 0.15758467 |
| 153 | NTRK3 | 0.15253303 |
| 154 | CAMK1D | 0.14974136 |
| 155 | MARK2 | 0.14129145 |
| 156 | PRKDC | 0.13334465 |
| 157 | MAPK14 | 0.12418718 |
| 158 | CSNK1A1L | 0.12225314 |
| 159 | CDK6 | 0.12085815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Pancreatic secretion_Homo sapiens_hsa04972 | 8.16345373 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.15805400 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.83342621 |
| 4 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 5.78928186 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.96854995 |
| 6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.93150856 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.55025914 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93249315 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.88642491 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.76922108 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.67455032 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53868191 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32328734 |
| 14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.24716392 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.23237770 |
| 16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22523310 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.20111996 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03499630 |
| 19 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00255229 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96838087 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95709233 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91388792 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88147622 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87659167 |
| 25 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86405998 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85410723 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84936798 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.82145545 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79680863 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79559013 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77592711 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70941755 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69964183 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69379127 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67571164 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 0.66222820 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65928003 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64347675 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63702852 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63113120 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63092756 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63044129 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62363060 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57775454 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57629275 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54796107 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53589008 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52842587 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48756922 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48383808 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47030385 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46707477 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46460317 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44932232 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43884417 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43496869 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42906543 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42094411 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.42037721 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41059210 |
| 61 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39066528 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38654111 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38349023 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.37924746 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37709380 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37318749 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.37229938 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36696900 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35978861 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35805392 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.34786579 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34628340 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33360344 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33350589 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.32978089 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32652618 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32001491 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29648314 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.29177943 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.29097004 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28418353 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.28146842 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28087649 |
| 84 | Prostate cancer_Homo sapiens_hsa05215 | 0.27870748 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27144027 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26446236 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26223979 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.25683195 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23404235 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.22859648 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.21144138 |
| 92 | Bile secretion_Homo sapiens_hsa04976 | 0.18791585 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17683713 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.17428157 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16910365 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16426743 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.16230548 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15382483 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.15347430 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15292114 |
| 101 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.15120619 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.15112231 |
| 103 | Proteasome_Homo sapiens_hsa03050 | 0.14729220 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14612280 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.14466314 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.12967583 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.12625197 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11552557 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.11191190 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.10421256 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.10217035 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.10189088 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.09773054 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09713007 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09566658 |
| 116 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.09465586 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.09460005 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.08854074 |
| 119 | Ribosome_Homo sapiens_hsa03010 | 0.08773539 |
| 120 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.08638889 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08457401 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.08386284 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.08333795 |
| 124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.07544006 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.07451257 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07279930 |
| 127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.07184461 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.06890695 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.05769963 |
| 130 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.05277444 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.05250118 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05239290 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03962206 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.03739789 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.03327159 |
| 136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.02113133 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.01647552 |
| 138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.01639972 |
| 139 | ABC transporters_Homo sapiens_hsa02010 | 0.00458431 |
| 140 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.1061659 |
| 141 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0967729 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | -0.0897593 |
| 143 | Tyrosine metabolism_Homo sapiens_hsa00350 | -0.0742923 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | -0.0733118 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0579226 |
| 146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0089512 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0021520 |
| 148 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0019878 |

